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ublingual Nitroglycerin Used
n Routine Tilt Testing Provokes a
ardiac Output-Mediated Vasovagal Response
anneke Gisolf, MSC,* Berend E. Westerhof, MSC,† Nynke van Dijk, MD,‡ Karel H. Wesseling, MSC,§
outer Wieling, MD, PHD,‡ John M. Karemaker, PHD*
msterdam, the Netherlands
OBJECTIVES We set out to determine the effect of sublingual nitroglycerin (NTG), as used during routine
tilt testing in patients with unexplained syncope, on hemodynamic characteristics and
baroreflex control of heart rate (HR) and systemic vascular resistance (SVR).
BACKGROUND Nitroglycerin is used in tilt testing to elicit a vasovagal response. It is known to induce venous
dilation and enhance pooling. Also, NTG is lipophilic and readily passes cell membranes, and
animal studies suggest a sympatho-inhibitory effect of NTG on circulatory control.
METHODS Routine tilt testing was conducted in 39 patients with suspected vasovagal syncope (age 36 
16 years, 18 females). Patients were otherwise healthy and free of medication. Before a loss
of consciousness set in, oncoming syncope was cut short by tilt-back or counter-maneuvers.
Finger arterial pressure was monitored continuously (Finapres). Left ventricular stroke
volume (SV) was computed from the pressure pulsations (Modelflow). Spontaneous barore-
flex control of HR was estimated in the time and frequency domains.
RESULTS During tilt testing, 22 patients developed presyncope. After NTG administration but before
presyncope, SV and cardiac output (CO) decreased (p  0.001), whereas SVR and HR
increased (p  0.001) in all patients. Arterial pressure was initially maintained. Baroreflex
sensitivity decreased after NTG. On Cox regression analysis, the occurrence of a vasovagal
response was related to a drop in SV after NTG (hazard ratio 0.86, p  0.005).
CONCLUSIONS The cardiovascular response to NTG is similar in vasovagal and non-vasovagal patients, but
more pronounced in those with tilt-positive results. The NTG-facilitated presyncope
appears to be CO-mediated, and there is no evidence of NTG-induced sympathetic





















eecurrent syncope is a common medical problem. Head-up
ilt testing with or without pharmacologic intervention has
een shown to be a useful diagnostic test to document a
endency toward vasovagal fainting (1–7). Nitroglycerin
NTG) is commonly administered to increase the diagnostic
ield of the procedure (8–10), because as potent venodila-
ors (11), nitrates might facilitate vasovagal syncope (VVS)
y enhancing venous pooling in the upright posture. Nitro-
lycerin has been proposed to enter smooth muscle cells
here it undergoes metabolic activation to nitric oxide
NO) (12,13). There is mounting evidence that NO donors
ave pronounced central effects (14). Nitroglycerin is lipid-
oluble and readily crosses cell membranes. Animal studies
uggest a direct effect of NTG on the central nervous
ystem, resulting in sympathetic inhibition (15). We there-
ore hypothesized that NTG facilitates a vasovagal reaction
n routine head-up tilt testing not only via venous vasodi-
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Manuscript received March 15, 2004; revised manuscript received March 26, 2004,3ccepted April 6, 2004.ation, but also by acting centrally on circulatory control and
nhibiting the baroreflex control of heart rate (HR) and
rterial peripheral resistance, thus leading to syncope by dual
athways. The purpose of this study was to investigate the
ffect of NTG, as used in routine tilt testing in otherwise
ealthy patients with a history of VVS, on hemodynamic
haracteristics and baroreflex control of HR and systemic
ascular resistance (SRV). We further sought to assess
hether an immediate cardiovascular response to NTG was
elated to the test outcome.
ETHODS
tudy population. The study group consisted of patients
ith suspected VVS, referred for routine tilt-table testing to
he Syncope Unit of the Academic Medical Center in the
eriod of June 2002 to July 2003. Excluded were patients
ith a history of cardiovascular disease, carotid sinus syn-
rome, or any disease that might affect the autonomic
ervous system, as well as patients using medication that
ight affect the circulation or circulatory control. Subse-
uently, we excluded patients who experienced a vasovagal
pisode before administration of NTG (n  2). A total of
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August 4, 2004:588–93 Effects of NTG in Routine Tilt Testingilt-test protocol and measurements. The tests were done
etween 9:00 AM and 1:00 PM in a temperature-controlled
oom (23°C). A manually operated tilt table with a footboard
as used. Blood pressure was measured continuously and
on-invasively using the Finapres Model 5 (TNO Biomedical
nstrumentation, Amsterdam, the Netherlands). Beat-to-beat
hanges in stroke volume (SV) were estimated by modeling
ow from arterial pressure (Modelflow, TNO Biomedical
nstrumentation) (16–18). The tilt-table test started with 5
in of supine rest, followed by 20 min head-up tilt (60°). If no
VS developed, NTG was administered sublingually (0.4 mg)
or an additional 15-min tilt duration (19). Oncoming syncope
as aborted by means of tilt-back or counter-maneuvers, such
s leg crossing (20), before a loss of consciousness set in. The
tudy was approved by the Medical Ethical Committee of the
cademic Medical Center, University of Amsterdam, the
etherlands.
ata acquisition and analysis. The Finapres arterial pres-
ure signal was analog to digital converted at 100 Hz and
tored on hard disk for off-line analysis. Mean arterial
ressure (MAP) was the true integral of the arterial pressure
ave over one beat divided by the corresponding beat
nterval. Heart rate was computed as the inverse of the
nterbeat interval (IBI) and expressed as beats per minute.
ardiac output (CO) was the product of SV and HR, and
VR was MAP at the heart level divided by CO. Beat-to-
eat values were computed and averaged per minute. Stroke
olume, CO, and SVR were set at 100% (baseline) in the
pright posture, 5 min before NTG administration, and
ariations were expressed as percentages of this baseline.
lopes were computed for the minute averages of HR,
ystolic and diastolic arterial pressure (SAP and DAP,
espectively), MAP, SV, CO, and SVR over a 4-min time
rame starting at NTG administration in all patients.
Of those patients who developed VVS during the tilt test,
inute averages were calculated for beat-to-beat data up to
point where a drop in HR and/or arterial blood pressure
receding the vasovagal episode was detected. To analyze
he hypotensive, presyncopal episode in tilt-positive pa-
ients, the last 15 s before the intervention, such as tilt-back,
Abbreviations and Acronyms
BRS  baroreflex sensitivity
CO  cardiac output
DAP  diastolic arterial pressure
HR  heart rate
IBI  interbeat interval
MAP  mean arterial pressure
NO  nitric oxide
NTG  nitroglycerin
SAP  systolic arterial pressure
SNP  sodium nitroprusside
SV  stroke volume
SVR  systemic vascular resistance
VVS  vasovagal syncopeas analyzed. waroreflex sensitivity (BRS). Beat-to-beat SAP and IBI
ime series were detrended and Hanning windowed. Power
pectral density and cross-spectra of SAP and IBI in the
ow-frequency band (0.06 to 0.15 Hz) were computed using
iscrete Fourier transform, as described elsewhere (21). For
ime-domain analysis of spontaneous BRS, we used the
ross-correlation method PRVXBRS (22), which is now a
tandard part of the software packages delivered with
ortapres and Finometer products (FMS, Amsterdam, the
etherlands). The SAP and IBI time series were resampled
t 1 Hz. In a 10-s window, the correlation and regression
lope between SAP and IBI were computed. Delays of 0- to
-s increments in IBI were computed, and the delay with
he highest positive coefficient of correlation was selected.
he slope between SAP and IBI was recorded as a BRS
stimate if the correlation was significant at p  0.01.
tatistical analysis. Variables were tested for normality
sing the Kolmogorov-Smirnov test and expressed as the
ean value  SD, unless stated otherwise. Responses to
ublingual NTG were analyzed using the non-parametric
est for two related samples (Wilcoxon signed rank test) or
he paired t test, where appropriate. Differences between
roups were analyzed using the non-parametric test for two
ndependent samples (Mann-Whitney U test) or the t test,
here appropriate. Pearson’s correlation coefficient was
omputed for the correlation between the BRS results in the
ime-frequency domain. The association between data
computed slopes) and test outcome (time to faint), includ-
ng censored data on those patients without VVS during the
est, was assessed using Cox regression analysis (SPSS for
indows, release 11.5.2). Significance of the Walt statistic
as computed.
ESULTS
ubjects. Nitroglycerin-induced presyncope in 22 (56%) of
he 39 otherwise healthy patients included in the study. The
verage age (36  16 years), height (175  10 cm), weight
73  15 kg), and distribution of gender did not differ
etween the patients who experienced near syncope during
he tilt test and those who did not. The time from
dministration of NTG to presyncope in the tilt-positive
atients ranged from 2 min, 50 s to 14 min, 50 s. All
asovagal patients indicated prodromal symptoms such as
ight-headedness or nausea. Data recording was stopped in
wo tilt-negative patients (in the fourth and tenth minute
fter NTG administration) because of technical reasons.
ardiovascular response to NTG. Hemodynamics during
to 1 min preceding and 1 to 4 min following NTG
dministration in all patients are summarized in Table 1.
efore NTG, patients were asymptomatic, and the average
AP was 87 mm Hg (range 67 to 101 mm Hg). One
atient became symptomatic in the third minute after
TG, another in the fourth minute. Systolic and mean
inapres blood pressures were well maintained after NTG,
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Effects of NTG in Routine Tilt Testing August 4, 2004:588–93lthough HR increased, CO diminished. Furthermore,
VR increased after NTG (p  0.001) (Fig. 1). During
hese periods, there were no significant differences in he-
odynamic characteristics between tilt-positive and tilt-
egative patients.
ower spectral density and BRS. After excluding one
ilt-positive patient from spectral analysis because of fre-
uent extrasystolic beats, for the remaining 38 of the 39
atients, the IBI low-frequency power density increased
fter NTG (p  0.05). The SAP low-frequency power also
Table 1. Cardiovascular Characteristics of All




SAP (mm Hg) 118 
MAP (mm Hg) 87 
DAP (mm Hg) 72 
HR (beats/min) 85 
SV (%) 98 
CO (%) 99 
SVR (%) 103 
Frequency-domain analysis
SAP LF power (mm Hg2)* 18 
IBI LF power (ms2)* 819 
BRS LF gain (ms/mm Hg)* 4.9 
Coherence* 0.66 
Time-domain analysis
BRS (ms/mm Hg)* 8.0 
*Results on 38 of 39 patients. †Paired samples t test. ‡Wilco
BRS  baroreflex sensitivity; CO  cardiac output; DA
interval; LF  low-frequency; MAP  mean arterial pressu
stroke volume; SVR  systemic vascular resistance.
igure 1. Hemodynamic response to NTG during the 60° tilt test. At 0 m
olume (SV); (C) cardiac output (CO); (D) systemic vascular resistance (S
verages and SEM. Open circles  negative tilt test; solid circles  positive tended to increase (p  0.12). The spectral power and BRS
stimates are given in Table 1. The BRS low-frequency gain
ecreased after the hemodynamic changes induced by
TG, as did the spontaneous BRS calculated in the time
omain (Fig. 1F). There were no differences in BRS or
ower spectral density between the patients with a negative
ersus positive test outcome in the selected periods. Al-
hough the BRS low-frequency gain results were lower than
he time-domain BRS estimates, the methods correlated
ell (Pearson’s r  0.79, p  0.001).
nts During Periods of 3 Minutes Before and
60° Head-Up Tilt
1 to 4 min
After NTG p Value
117  12 NS†
87  10 NS†
75  9 0.001†
95  17 0.001‡
84  10 0.001‡
93  8 0.001†
111  11 0.001‡
24  21 NS‡
1,095  866 0.05‡
3.8  2.4 0.01‡
0.65  0.16 NS‡
6.1  2.8 0.001‡
ned rank test. Data are presented as the mean value  SD.
iastolic arterial pressure; HR  heart rate; IBI  interbeat
G  nitroglycerin; SAP  systolic arterial pressure; SV 
roglycerine is administered. (A) mean arterial pressure (MAP); (B) stroke
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August 4, 2004:588–93 Effects of NTG in Routine Tilt Testingomputed trends after NTG administration. Cardiovas-
ular trends in patients who experienced presyncope and
hose who did not are shown in Figure 1. The tilt-positive
atients demonstrated a greater drop in SV, CO, and
rterial blood pressure. The HR in the period preceding
TG appears higher in the tilt-negative group; however,
his difference is not significant (88 17 beats/min vs. 83
2 beats/min, p  0.3). To avoid statistical testing of
pisodes where the number of tilt-positive patients was
reatly reduced, trends were analyzed by calculation of the
lope during the first 4 min after NTG administration (Fig.
). The tilt-positive patients had a steeper drop in SV
ompared with the tilt-negative patients (p  0.05). The
oncomitant rise in HR was also steeper in the tilt-positive
atients (p  0.05).
asovagal episode. During the last 15 s before tilt-back or
ounter-maneuver, the tilt-positive patients showed marked
ypotension with SAP of 81  11 mm Hg and DAP of 54
10 mm Hg. Heart rate ranged from 45 to 111 beats/min
uring this period (mean 78  23 mm Hg). Five of the 22
ilt-positive patients had a HR 100 beats/min, whereas
even had a HR 60 beats/min. Stroke volume was 68 





(95% CI) p Value
odel A: slope of HR
(beats/min)
5.66 1.12 (1.02–1.22) 0.017
odel B: slope of SV
(%/min)
7.91 0.86 (0.77–0.95) 0.005
igure 2. Computed trends of minute averages over 4 min immediately
fter nitroglycerine administration during 60° tilt test. (A) Slope of heart
ate; (B) Slope of stroke volume. Open circles  negative tilt test; solid
ircles  positive tilt test. Bars indicate SEM.(I  confidence interval; other abbreviations as in Table 1.2% of baseline, CO was 63  14%, and SVR was 126
44%. Both SV and CO during the vasovagal episode were
ower than those of tilt-negative patients in their last minute
f tilt, who had an average SV of 83 15% (p 0.002) and
O of 92  12% (p  0.001) (Figs. 1B and 1C). During
ear syncope, in 18 of the 22 tilt-positive patients, SVR was
ncreased compared with baseline. The SVR and HR
esponses were not related to age.
ox regression model. Using the calculated slopes to
odel the tilt-test outcome (time to presyncope), Cox
egression showed that a rise in HR was related to the
ccurrence of a vasovagal response during tilt testing (Fig.
A, Table 2). The drop in SV was also related to the test
utcome; a steep drop in SV was associated with an
ncreased hazard of a vasovagal response (Fig. 2B, Table 2).
odeling both slopes of SV and HR together does not
mprove the model, as these variables are correlated (r 
0.54, p  0.01).
ISCUSSION
he present findings demonstrate that administration of
TG during routine tilt testing of otherwise healthy pa-
ients suspected of VVS leads to a rapid drop in SV, a rise
n SVR and HR, and initially a maintained arterial blood
ressure in patients with a positive test outcome, as well as
n those with a negative test outcome. This implies an
dequate arterial resistance response to NTG-induced ve-
ous dilation and pooling, rendering impaired circulatory
ontrol due to NTG unlikely. The cardiovascular response
o NTG was similar in vasovagal and non-vasovagal pa-
ients, but the response was more pronounced in tilt-
ositive patients; the reduction in SV after NTG adminis-
ration was related to the tilt-test outcome. Despite an
ncrease in HR, there was a reduction in CO. A NTG-
nduced vasovagal response, therefore, appears CO-
ediated and is not preceded by a decrease in SVR.
ffect of NTG on circulatory control. Baroreflex sensi-
ivity was decreased in the period after NTG, which,
ogether with the rise in HR and SVR, suggests sympathetic
ctivation. Interestingly, the rises in HR and SVR after
TG were not preceded by a reduction in arterial pressure.
ossible explanations for this are, first, that arterial barore-
eptors respond to mechanical deformation and not pres-
ure, and small reductions in effective blood volume are
nown to trigger baroreflex adjustments of arterial pressure
23); and second, another pathway leading to an increase in
VR is via the cardiopulmonary reflex (24), which is
ensitive to changes in venous pressure. Activation of the
ardiopulmonary reflex is likely after NTG administration,
hich is known to result in venodilation and pooling of
lood (11).
We found no difference in BRS between tilt-positive and
ilt-negative patients before or after NTG administration.
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Effects of NTG in Routine Tilt Testing August 4, 2004:588–93ot comparable, however, as they studied the BRS during
ilt-back immediately after full syncope, whereas we com-
uted BRS in the lead-up to presyncope.
The present findings indicate an increase in SVR after
TG administration in all patients and a sustained increase
n SVR at the onset of presyncope. This seems at odds with
revious reports of an early progressive decrease in SVR
eading to syncope in healthy young subjects without use of
TG (26). The supine recording is commonly used as a
ontrol period for expressing SVR as percentage of baseline.
n the present study, however, we explicitly omitted the
upine recording as baseline and used the upright tilt
ecording before NTG administration as baseline to avoid
V estimations during posture change (27). After 20-min
pright tilt with corresponding cardiovascular adjustments
o orthostatic stress, NTG was administered. We have not
nalyzed the changes in SV, CO, and SVR from the supine
o the upright tilt position, and we therefore limit our
onclusions to the effect of NTG administration during
outine tilt testing in otherwise healthy, medication-free
atients.
entral effects of NTG. Since the discovery that NO is
ot only a regulator of smooth muscle tone but also a
euromodulator within the central and peripheral nervous
ystem (28,29), it is likely that the cardiovascular actions of
O are not confined to its direct effects on blood vessels,
ut rather include effects on the central and peripheral
ervous system (14). In humans, the effect of NO donors on
ardiovascular autonomic control has been investigated
sing infusions of sodium nitroprusside (SNP), and the
esults suggest that SNP had no effects on the cardiac/vagal
imb of the baroreflex (30). However, SNP is hydrophilic,
nd the compound has difficulty crossing membranes. Ni-
roglycerin, on the other hand, is lipophilic, and the com-
ounds readily enter cells to form NO. The results of animal
tudies suggest that within the central nervous system there
re sites that modulate the cardiovascular effects of NTG,
nd the hypotensive effects of NTG may be modified by
entral noradrenergic activity controlling the circulation
15). In the present study, we demonstrate that BRS,
stablished using time and frequency domain methods,
ecame diminished after sublingual NTG. The increase in
AP and SVR, however, together with the increase in HR
nd IBI low-frequency spectral power, provides strong
ircumstantial evidence of increased sympathetic outflow
31). We therefore consider sympathico-inhibition due to a
entral effect of NTG, as used during routine clinical tilt
esting, unlikely.
tudy limitations. The present results were obtained in
atients with no cardiovascular or neurologic diseases and
o medication. The patient group has thus been selected,
esulting in a group that is relatively younger and healthier
han the total of patients referred for unexplained syncope.
ncluded were only those patients who did not have a
asovagal episode before NTG, thus excluding the most
utspoken cases. A vasovagal response was aborted before aoss of consciousness set in, and we therefore limited our
nalysis and our conclusions to the prodromal phase and the
nset of a vasovagal response.
We used a new method of BRS computation (time-
omain cross correlations) and an established method
frequency-domain cross-spectral calculations). Although
hese methods correlated well, the frequency-domain BRS
ain was lower than the time-domain BRS. Considering
hat both methods calculated the correlation between spon-
aneous variations in SAP and IBI, we would ideally expect
dentical results. However, with the frequency-domain
ethod, we made a frequency-band selection (i.e., the
ow-frequency band), whereas the time-domain method, in
rinciple, includes all frequencies, which might explain the
reater BRS estimates we found using the latter method.
onclusions. Our study of otherwise healthy patients sus-
ected of VVS demonstrates a rapid decrease in SV and an
ncrease in SVR and HR after NTG administration during
ilt testing. We found strong indications that sublingual
TG induces an increase in sympathetic outflow, resulting
n initially maintained arterial pressure. The NTG-triggered
yncopal episode is not preceded by a decrease in SVR, but
ppears CO-mediated. Our finding that the decrease in SV
fter NTG administration is related to the time to presyn-
ope supports this.
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